Catalyst Wire Dossier Catalyst Wire Dossier

INS365 Ophthalmic Solution

INS365 · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for INS365 Ophthalmic Solution, covering 2015-08-27 to 2016-11-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease [Phase 3]

See pricing